Validation of the 0-to-10 Medication Adherence Scale against the Medication Possession Ratio: A comparative analysis

The 0-to-10 Medication Adherence Scale is a quick, effective tool for assessing medication adherence, correlating strongly with the MPR. Its simplicity supports its integration into clinical practice.

Authors

Institutions

Publication Details

Journal
American Journal of Health-System Pharmacy
Published
2025-09-25
DOI
https://doi.org/10.1093/ajhp/zxaf254
Primary Topic
Medication Adherence and Compliance
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Validation of the 0-to-10 Medication Adherence Scale against the Medication Possession Ratio: A comparative analysis

Nelson Augusto Rosário Filho, Oralia V. Bazaldua, DeWayne Davidson
American Journal of Health-System Pharmacy
Medication Adherence and Compliance
article

Validation of the 0-to-10 Medication Adherence Scale against the Medication Possession Ratio: A comparative analysis

Nelson Augusto Rosário Filho, Oralia V. Bazaldua, DeWayne Davidson
article en

Abstract

The 0-to-10 Medication Adherence Scale is a quick, effective tool for assessing medication adherence, correlating strongly with the MPR. Its simplicity supports its integration into clinical practice.

American Journal of Health-System PharmacyVol. 82(Supplement_6)
The University of Texas at San Antonio Health Science Center (US), Health First (US), Urology San Antonio (US)
Openalex Percentile: Top 70%
Medication Adherence and Compliance
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.